Cartesian Therapeutics, Inc. (RNAC)
NASDAQ · Manufacturing · Pharmaceutical preparations
RNAC price, last 12 months
Key stats
- Previous close
- $6.30
- Open
- $6.33
- Day range
- $5.80 – $6.33
- 52-week range
- $5.60 – $11.00
- Volume
- 384.7K
- Avg volume (20 days)
- 150.8K
- Market cap
- $193.7M
Performance
Technicals and fundamentals
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $193.7M